Section 67 Offences under Part III.C1

United Kingdom

(1)

The following provisions of this section shall have effect subject to sections 121 and 122 of this Act.

F1(1A)

Any person who gives a prescription or directions or administers a medicinal product in contravention of a condition imposed by an order under section 58 of this Act by virtue of subsection (4A) of that section shall be guilty of an offence.

(1B)

Any person who—

(a)

is an appropriate practitioner F2 within the meaning of regulation 214 of the 2012 Regulations ; and

(b)

gives a prescription or directions in respect of a medicinal product of a description or class in relation to which he is not an appropriate practitioner,

shall be guilty of an offence.

(2)

Any person who contravenes any of the following provisions of this Part of this Act, that is to say, sections F363 and 64, or who contravenes F4... any order made under section 62 of this Act, shall be guilty of an offence.

(3)

Where a medicinal product is sold, supplied or imported in contravention of an order made under section 62 of this Act, any person who, otherwise than for the purpose of performing or exercising a duty or power imposed or conferred by or under this Act or any other enactment, is in possession of the medicinal product, knowing or having reasonable cause to suspect that it was sold, supplied or imported in contravention of the order, shall be guilty of an offence.

F5(3A)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4)

Any person guilty of an offence under F6subsection (1A), (1B), (2) or (3) of this section shall be liable—

(a)

on summary conviction, to a fine not exceeding £400;

(b)

on conviction on indictment, to a fine or to imprisonment for a term not exceeding two years or to both.

F7(5)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(6)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations

Textual amendments

F1: S. 67(1A)(1B) inserted (6.3.2002 for certain purposes and 1.4.2002 otherwise) by 2001 c. 15, s. 63(7)(a) (with ss. 64(9), 65(4)); S.I. 2002/1095, art. 2(1) (with transitional provisions in art. 3)
F2: Words in s. 67(1B)(a) substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(2) (with Sch. 32)
F3: Words in s. 67(2) substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(3)(a) (with Sch. 32)
F4: Words in s. 67(2) omitted (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(3)(b) (with Sch. 32)
F5: S. 67(3A) repealed (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(4), Sch. 35 (with Sch. 32)
F6: Words in s. 67(4) substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(5) (with Sch. 32)
F7: S. 67(5)(6) repealed (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 9(6), Sch. 35 (with Sch. 32)

Modifications

C1

S. 67 extended by S.I.s 1982/425, art. 3, 1984/187, art. 2 and extended with modifications by S.I. 1985/1403, art. 3(1)

S. 67 applied (1.1.1995) by S.I. 1994/3142, reg. 18(2)

S. 67 applied (31.3.1997) by S.I. 1997/322, reg. 34, Sch. 5

Notes on Part III

Modifications

C1: Part III (ss.51-68) modified (1.1.1995) by S.I. 1994/3144, reg. 9(9)
C2: Pt. III amendment to earlier affecting provision SI 1994/3144 reg. 9 (30.10.2005) by Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005 (S.I. 2005/2759), regs. 1(a), 2(12)